TipRanks
Lexston Life Sciences Corp. (TSE:LEXT)
:LEXT
Canadian Market
Want to see TSE:LEXT full AI Analyst Report?

Lexston Life Sciences Corp. (LEXT) Income Statement

6 Followers

Lexston Life Sciences Corp. Income Statement

Last quarter (Q4 2026), Lexston Life Sciences Corp.'s total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q4, Lexston Life Sciences Corp.'s net income was C$-334.45K. See Lexston Life Sciences Corp.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
May 26Aug 25Aug 24May 23Aug 22
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 361.01K
Gross Profit
C$ 0.00C$ 0.00C$ -26.39KC$ -29.80KC$ 241.49K
Operating Expenses
C$ 1.35MC$ 1.35MC$ 707.89KC$ 1.04MC$ 2.11M
Depreciation and Amortization
C$ 0.00C$ 26.39KC$ 26.39KC$ 29.80KC$ 31.98K
EBITDA
C$ -1.35MC$ -1.54MC$ -648.32KC$ -841.73KC$ -2.29M
Operating Income
C$ -1.35MC$ -1.35MC$ -674.72KC$ -871.53KC$ -2.00M
Other Income/Expenses
C$ 0.00C$ -194.99KC$ -59.56KC$ -94.54KC$ -320.59K
Pretax Income
C$ -1.35MC$ -1.54MC$ -734.28KC$ -966.07KC$ -2.32M
Net Income
C$ -1.42MC$ -1.62MC$ -867.71KC$ -1.11MC$ -2.32M
Per Share Metrics
Basic EPS
C$ -0.08C$ -0.34C$ -0.27C$ -0.39C$ -2.08
Diluted EPS
C$ -0.08C$ -0.34C$ -0.27C$ -0.39C$ -2.08
Weighted Average Shares Outstanding
18.30M 4.75M 3.19M 2.86M 1.12M
Weighted Average Shares Outstanding (Diluted)
18.30M 4.75M 3.19M 2.86M 1.12M
Currency in CAD

Lexston Life Sciences Corp. Earnings and Revenue History